| Product NDC: | 0186-6020 |
| Proprietary Name: | NEXIUM |
| Non Proprietary Name: | Esomeprazole sodium |
| Active Ingredient(s): | 20 mg/5mL & nbsp; Esomeprazole sodium |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0186-6020 |
| Labeler Name: | AstraZeneca LP |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021689 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20050503 |
| Package NDC: | 0186-6020-01 |
| Package Description: | 10 VIAL in 1 CARTON (0186-6020-01) > 5 mL in 1 VIAL |
| NDC Code | 0186-6020-01 |
| Proprietary Name | NEXIUM |
| Package Description | 10 VIAL in 1 CARTON (0186-6020-01) > 5 mL in 1 VIAL |
| Product NDC | 0186-6020 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Esomeprazole sodium |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20050503 |
| Marketing Category Name | NDA |
| Labeler Name | AstraZeneca LP |
| Substance Name | ESOMEPRAZOLE SODIUM |
| Strength Number | 20 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |